Aldeyra Therapeutics, Inc. (ALDX) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry Eye - Slideshow (NASDAQ:ALDX) 2025-11-16

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]